Cargando…
Targeting hyaluronic acid synthase-3 (HAS3) for the treatment of advanced renal cell carcinoma
BACKGROUND: Hyaluronic acid (HA) promotes cancer metastasis; however, the currently approved treatments do not target HA. Metastatic renal carcinoma (mRCC) is an incurable disease. Sorafenib (SF) is a modestly effective antiangiogenic drug for mRCC. Although only endothelial cells express known SF t...
Autores principales: | Wang, Jiaojiao, Jordan, Andre R., Zhu, Huabin, Hasanali, Sarrah L., Thomas, Eric, Lokeshwar, Soum D., Morera, Daley S., Alexander, Sung, McDaniels, Joseph, Sharma, Anuj, Aguilar, Karina, Sarcan, Semih, Zhu, Tianyi, Soloway, Mark S., Terris, Martha K., Thangaraju, Muthusamy, Lopez, Luis E., Lokeshwar, Vinata B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9801563/ https://www.ncbi.nlm.nih.gov/pubmed/36581895 http://dx.doi.org/10.1186/s12935-022-02818-1 |
Ejemplares similares
-
Molecular targeting of renal cell carcinoma by an oral combination
por: Jordan, Andre R., et al.
Publicado: (2020) -
Molecular Oncology of Bladder Cancer from Inception to Modern Perspective
por: Lokeshwar, Soum D., et al.
Publicado: (2022) -
Hyaluronic acid family in bladder cancer: potential prognostic biomarkers and therapeutic targets
por: Morera, Daley S, et al.
Publicado: (2017) -
The Effect of Bupivacaine on the Efficacy of Antibiotic Coating on Penile Implants in Preventing Infection
por: Lokeshwar, Soum D., et al.
Publicado: (2019) -
Hyaluronic Acid and Hyaluronidase: Accurate Tumor Markers and Tumor Progression Regulators
por: Lokeshwar, Vinata, et al.
Publicado: (2001)